$$$$$- GLP-1/Glucagon dual agonist for type 2 diabetes and obesity and phase 2 drug candidate for the treatment of androgen deficiency
In a recently completed phase 2 study of 420 patients with type 2 diabetes, subjects receiving the highest dose of TT401 peptide once weekly demonstrated significantly superior weight loss compared with currently approved extended release exenatide and placebo after 12 and 24 weeks of treatment.
we've got nothing but tailwind going into Aug. 3 earnings, payments from TSRO and PFE..Rayaldee launch, 4K reimbursement,.. HGH results for children..and Claros gets closer...
with BRLI being a fantastic catalyst to marketing for tsro's NDA filing for niraparib...
the downside risk 3-4%...upside conservative 15% into earnings..
who gives a flying #$%$ "why?"...the facts is what the facts is...dig?
I'm mixin' up some grillin' sauce for bear steaks..
I thought we showed terrific stability amidst the storm we had on Friday if we can remain above $9 these next few trading days looks like a solid floor to me...thanks for the update..
lotsa free PR this simmer and FB Live videos galore...
there are plenty of men with prostate enlargement issues that will get 4K screening..and gladly co-pay!
I rather doubt they have any ability to control how the investing community, institutional or retail behaves as it pertains to supply/demand equation on a daily trading basis, they must share information of a material nature in a timely fashion.
Frosty has money but he wouldn't just throw it away he has big plans for his charitable foundation..
with Michael, Magic, Kareem, Bill,..Larry...
man, y'all did it to yourselves don't blame the longs...loooolololol